Unknown

Dataset Information

Anti-proliferative therapy for HIV cure: a compound interest approach.


ABSTRACT: In the era of antiretroviral therapy (ART), HIV-1 infection is no longer tantamount to early death. Yet the benefits of treatment are available only to those who can access, afford, and tolerate taking daily pills. True cure is challenged by HIV latency, the ability of chromosomally integrated virus to persist within memory CD4+ T cells in a non-replicative state and activate when ART is discontinued. Using a mathematical model of HIV dynamics, we demonstrate that treatment strategies offering modest but continual enhancement of reservoir clearance rates result in faster cure than abrupt, one-time reductions in reservoir size. We frame this concept in terms of compounding interest: small changes in interest rate drastically improve returns over time. On ART, latent cell prolifer

SUBMITTER: Reeves DB 

PROVIDER: S-EPMC5479830 | biostudies-literature | 2017 Jun

REPOSITORIES: biostudies-literature